Literature DB >> 9199899

Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals.

J H Haseman1, G T Lemmel, E Y Rahmani, D K Rex.   

Abstract

BACKGROUND: Colonoscopy is the gold standard for the detection of colon polyps and cancers, but failed detections can occur and the reasons are incompletely understood.
METHODS: During a retrospective evaluation of the sensitivity of barium enema and colonoscopy in 20 Indiana Hospitals, we encountered 47 cases of colorectal cancer in which a colonoscopy performed within 3 years of the diagnosis had not detected the cancer. Cases were reviewed for location of tumor, extenuating factors, pathologic features, delay in diagnosis from failed detection, and who performed the examination.
RESULTS: Failed detection was more likely when colonoscopy was performed by a nongastroenterologist than a gastroenterologist (odds ratio 5:36, 95% CI [2.94,9.77]). Twenty-seven cancers were "missed," and 20 were estimated to be not reached. However, the location of missed tumors and a general absence of adequate documentation of cecal intubation suggested that some cecal and ascending colon cancers recorded as missed may actually have been not reached. Variation in sensitivity among gastroenterologists suggested that meticulous examination is also important in maximizing sensitivity.
CONCLUSIONS: These cases suggest several factors that might improve the quality and sensitivity of colonoscopy: (1) examiners should receive adequate training, (2) cecal intubation rates should be high, (3) cecal intubation should be verified by specific landmarks in all cases, (4) failure to reach the cecum should be followed by prompt barium enema, and (5) meticulous examination would appear to improve sensitivity for cancer detection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199899     DOI: 10.1016/s0016-5107(97)70172-x

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  36 in total

1.  Principles of privileging and credentialing for endoscopy and colonoscopy.

Authors:  S D Wexner; G M Eisen; C Simmang
Journal:  Surg Endosc       Date:  2002-01-17       Impact factor: 4.584

2.  Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight.

Authors:  R Kiesslich; M F Neurath
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 3.  Quality indicators in colonoscopy.

Authors:  Robert Enns
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

4.  Canadian credentialing guidelines for colonoscopy.

Authors:  J Romagnuolo; R Enns; T Ponich; J Springer; D Armstrong; A N Barkun
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

5.  Granting of privilege for gastrointestinal endoscopy : This privilege guideline was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee.

Authors:  Yumi Hori
Journal:  Surg Endosc       Date:  2008-03-26       Impact factor: 4.584

Review 6.  Indications, stains and techniques in chromoendoscopy.

Authors:  P J Trivedi; B Braden
Journal:  QJM       Date:  2012-10-24

7.  Polyp surveillance.

Authors:  W Donald Buie; Anthony R MacLean
Journal:  Clin Colon Rectal Surg       Date:  2008-11

Review 8.  Interval cancers after colonoscopy-insights and recommendations.

Authors:  Silvia Sanduleanu; Ad M Masclee; Gerrit A Meijer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

9.  Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding.

Authors:  M Mylonaki; A Fritscher-Ravens; P Swain
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

10.  A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status.

Authors:  M A Korsten; A M Spungen; A R Rosman; H R Ancha; J B Post; S Shaw; K K Hunt; R Williams; W A Bauman
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.